Potential problems include skin irritation, wasted money, and putting off proper treatment
Product Specifications Laboratory Handling Store lyophilised vials at -20C
As the new obesity pharmacotherapies will lead up to 1525% mean WL, intensive lifestyle interventions may provide small additional WL benefit to these treatments [11, 106]
(May check a serum level 2 hours after the load.) This is not often done, but could be considered for patients with unusual pharmacokinetics (e.g., morbid obesity)
The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials
Common GLP-1 RAs include: Tirzepatide (Mounjaro, Zepbound) Orforglipron (Foundayo) Semaglutide (Ozempic, Wegovy) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Exenatide (Byetta, Bydureon) Are GLP-1 medications safe during pregnancy